NCCN Guidelines Panel Disclosures

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
James S. Barthel, MD	CSA, Inc.	None	None	None	12/3/2009
Kelli Bullard Dunn, MD	None	None	None	None	12/9/2009
Randall W. Burt, MD	None	Myriad Genetic Laboratories, Inc.; Archimedes Inc.	None	None	12/3/2009
Jamie A. Cannon, MD					Pending
Donald S. David, MD	None	None	None	None	11/18/2009
Mary Dwyer, MS	None	None	None	None	7/15/2010
Dayna S. Early, MD	None	None	None	None	11/17/2009
James M. Ford, MD	None	None	None	None	11/18/2009
Francis M. Giardiello, MD, MBA	None	None	None	None	7/1/2009
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	8/30/2010
Stephen B. Gruber, MD, PhD, MPH	National Cancer Institute	Myriad Genetic Laboratories, Inc.	None	None	12/3/2009
Amy Halverson, MD	None	None	None	None	9/28/2009
Stanley R. Hamilton, MD	National Cancer Institute	None	None	None	3/26/2010
Maria Ho, PhD	None	None	None	None	7/15/2010
Mohammad K. Ismail, MD	None	None	None	None	5/18/2010
Kory Jasperson, MS, CGC	None	None	None	None	7/22/2009
Audrey J Lazenby, MD	None	None	None	None	11/18/2009
Patrick M Lynch, MD, JD	None	Myriad Genetic Laboratories, Inc.	None	None	12/9/2009
Edward W. Martin, MD	None	None	None	None	11/18/2009
Robert J. Mayer, MD	None	None	None	None	7/14/2009
Joan S. McClure, MS	None	None	None	None	7/18/2010
Reid M. Ness, MD, MPH	None	None	None	None	7/1/2009
Dawn Provenzale, MD, MS	None	None	None	None	12/9/2009
M. Sambasiva Rao, MD	None	None	None	None	11/18/2009
Moshe Shike, MD	None	None	None	None	12/16/2009
Gideon Steinbach, MD, PhD	None	None	None	None	11/30/2009
Jonathan P. Terdiman, MD	None	None	None	None	11/18/2009
David Weinberg, MD, MSc	National Cancer Institute	Mode Diagnostics	None	None	12/3/2009

NCCN Website Supporters

National Comprehensive Cancer Network

About NCCN